Top UK Cancer Centre Chooses IMS MAXIMS

A new web-based electronic patient records system is being swiftly introduced at a leading cancer centre thanks to an extension of its contract with IMS MAXIMS. The agreement follows a full options appraisal in which Clatterbridge Centre for Oncology NHS Foundation Trust (CCO) measured IMS against other commercially available alternatives and against the nationally-funded programme.

World-class information systems are essential to CCO, which is an internationally-renowned centre for oncology with 7,500 new patients a year. The hospital offers a wide range of complex and sophisticated care, and it also provides visiting medical and nursing teams to deliver further cancer services at general hospitals across Merseyside, Cheshire and the Isle of Man. As such the Foundation Trust needs patient record systems which are secure, flexible, robust and tailored precisely to its needs.

The options appraisal took place seven years into an existing 10-year contract with IMS MAXIMS. The three-year extension means the partnership will continue to 2015. It will bring an immediate upgrade of all IMS MAXIMS applications currently deployed at CCO, allowing staff and patients to benefit from the latest web based applications. The agreement will also allow the trust to make rapid progress with other projects.

Tom Poulter, CCO's Head of Information Management and Technology, said: "IMS MAXIMS was helpful and constructive throughout the appraisal, which was designed to determine our precise needs and direction of travel in the years ahead. They were keen to meet our specific requirements and we are now on a very solid footing for delivering a whole range of benefits."

IMS MAXIMS, an approved ASCC supplier, has a proven track record of delivering on time and meeting the objectives of the National Programme for IT (NPfIT) and the Clinical 5. The new agreement will see the improvements in place and running by the end of the 2010/11 financial year. Among the changes will be an upgrade of the existing patient administration system (PAS) with the introduction of WebPAS, which offers improved usability, an updated look and feel, and which also, integrates with MAXIMS clinical modules.

A second aspect of the deal involves a MAXIMS web upgrade which will see a move from a thick client to an entirely web-based system. Poulter said: "This means we won't have to install additional client software every time we upgrade. As there are 600 computers, that makes a big difference to our system administration and technical overheads - saving time and money because it frees IT staff to do other things. It will also bring greater flexibility, allowing healthcare professionals to access MAXIMS wherever they are, using a secure web portal."

The IMS MAXIMS agreement will help cut waiting times by improving radiotherapy workflow. This is thanks to the introduction of an electronic action sheet for consultant oncologists. "The paper forms used at present can take 1.8 days to go through the system. If a consultant running a clinic at the Royal Liverpool Hospital fills in a treatment form on a Friday it can be Monday before it is dealt with at our main hospital. The new system will be instantaneous, having a direct impact on patient waiting times," said Poulter.

The trust has ambitious plans, aiming to go beyond the Clinical 5 to achieve what it calls the Clinical 5+. This will eliminate the need to have paper-based records moving through the system. All records, in all formats, will be available to those who need them, wherever they are. IMS is playing a key role in making this vision a reality, by helping with the electronic document and records management system (EDRMS) integration.

"An early decision to extend the contract with IMS has enabled us to benefit from a range of system enhancements on a cost-neutral basis and we look forward to working closely with IMS to implement the Clinical 5+," added Poulter.

IMS MAXIMS is a highly customer-focused company which is proud of the close and creative partnerships it develops with clients such as CCO, and the role it plays helping the NHS improve patient care.

Shane Tickell, IMS MAXIMS CEO, said: "We have a long and very strong relationship with CCO and have proven our ability to provide tailor-made solutions for its unique needs. The Trust's confidence in the IMS MAXIMS solutions has been demonstrated by the fact that it has made such an early decision to extend our contract. It shows great faith in our ability to stay ahead of the competition and to deliver the world-class clinical and administrative systems needed by a leading oncology centre."

About IMS MAXIMS
The IMS MAXIMS products currently deployed at CCO include Oncology, PAS, Nursing, Therapies, Radiotherapy Scheduling, ADT, Order Communications and Patient Journey Management.

IMS MAXIMS specialise in developing clinical and administrative software solutions and currently supports more than 100 organisations and 10,000 users of IMS MAXIMS products.

Clatterbridge Centre for Oncology, Wirral Health Informatics Service and IMS MAXIMS, won the 2004 prize for best use of IT in the health service at the Health IT Effectiveness Awards at Healthcare Computing for their therapeutic radiography scheduling project.

Clatterbridge Centre for Oncology NHS Foundation Trust delivers treatment for patients through radiotherapy and chemotherapy services. To find out more visit the website at www.ccotrust.nhs.uk.

To find out more about IMS MAXIMS and its products visit the website at www.imsmaxims.com.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Brain Imaging may Identify Patients Like…

By understanding differences in how people’s brains are wired, clinicians may be able to predict who would benefit from a self-guided anxiety care app, according to a new analysis from...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...

The Human Touch of Doctors will Still be…

AI-based medicine will revolutionise care including for Alzheimer’s and diabetes, predicts a technology expert, but it must be accessible to all patients. Healing with Artificial Intelligence, written by technology expert Daniele...

Stepping for Digital Rewards

Walking is well known to have significant health benefits, but few people achieve the daily recommended steps. Fortunately, mobile health (mHealth) applications have emerged as promising tools to promote physical...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...